No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Survivin targeted immunotherapy is a type of oncology drug used to treat cancer. It is a form of immunotherapy, which is a type of treatment that uses the body's own immune system to fight cancer. Survivin is a protein that is found in high levels in many types of cancer cells. By targeting this protein, the immune system can be used to attack and destroy cancer cells. This type of therapy has been shown to be effective in treating a variety of cancers, including breast, lung, and colorectal cancer.
Survivin targeted immunotherapy is a relatively new form of treatment, and is still being studied and developed. It is an exciting area of research, as it has the potential to provide a more targeted and effective form of cancer treatment.
Some companies in the Survivin targeted immunotherapy market include Merck, Bristol-Myers Squibb, and AstraZeneca. Show Less Read more
